The present invention generally relates to medical systems and apparatus and uses thereof for treating obesity or obesity-related diseases, and more specifically, relates to access ports and methods for applying the same to bodily tissue.
Adjustable gastric banding apparatus have provided an effective and substantially less invasive alternative to gastric bypass surgery and other conventional surgical weight loss procedures. Despite the positive outcomes of invasive weight loss procedures, such as gastric bypass surgery, it has been recognized that sustained weight loss can be achieved through a laparoscopically-placed gastric band, for example, the LAP-BAND® (Allergan, Inc., Irvine, Calif.) gastric band or the LAP-BAND AP® (Allergan, Inc., Irvine, Calif.) gastric band. Generally, gastric bands are placed about the cardia, or upper portion, of a patient's stomach forming a stoma that restricts food's passage into a lower portion of the stomach. When the stoma is of an appropriate size that is restricted by a gastric band, the food held in the upper portion of the stomach may provide a feeling of satiety or fullness that discourages overeating. Unlike gastric bypass procedures, gastric band apparatus are reversible and require no permanent modification to the gastrointestinal tract.
Medical implants, including gastric band systems, for performing therapeutic functions for a patient are well known. Such devices include pace makers, vascular access ports, injection ports (such as used with gastric banding systems) and gastric pacing devices. Such implants need to be attached, typically subcutaneously, in an appropriate place in order to function properly.
Many implantable medical devices are secured with sutures. For example, when inserting a gastric band and an associated access port, the associated access port may be sutured into place with sutures against the rectus muscle sheath. Such placement of the sutures is often challenging because the associated access port is placed below several inches of bodily tissue (e.g., fat), and suturing the associated access port often takes as long as placing the gastric band itself.
Additionally, the sutures can cause post surgical pain for the patient due to the inherent pulling and slight tearing of the tissue pieces by and adjacent to the suture.
Also, it is common for medical professionals desiring to add or remove fluid via a needle through the access port to palpitate the skin to locate the implanted port. The medical professional has a general idea of the top surface of the port, but occasionally will accidentally miss the septum and puncture the tube and/or tissue surrounding or adjacent to the port.
Further, some body-related systems utilize retention geometry for the access port attachment such as Bestetti, et al., U.S. Pat. No. 6,270,475. However, Bestetti discloses a percutaneous access port not a subcutaneous access port. Similarly, Svensson, et al., U.S. Pat. No. 5,098,397, discloses a percutaneous access port not a subcutaneous access port.
Accordingly, there remains a need for a procedure to implant medical devices in a quick, easy and efficient manner, utilizing as small of an incision as possible which reduces the likelihood of future discomfort for the patient and protects the elements from errant needle strikes.
The present invention, in one embodiment, includes an implantable fluid access port of an adjustable gastric banding system coupled to the tissue of a patient. The port is configured to facilitate fluid transfer to and from the gastric banding system. The device includes a top housing section including a top opening, a septum surface, a bottom exit tube coupling, and a bottom housing section with a substantially circular side wall. A partial interior vessel may be formed between the fluid seal created between the bottom surface of the septum and the interior surfaces of the bottom housing portion.
In some embodiments, the implantable port may be configured to shield a coupled tube from inadvertent needle puncture using at least one of the orientation of the bottom exit tube coupling, needle entry orientation, or the structures of the body of the implantable port. The bottom exit tube coupling may be configured to provide a partial anchoring of the implantable port in a pre-selected position.
The device may include a porous coupling member having a top surface and a bottom surface. The porous coupling member may be integral to the implantable fluid access port or coupled to the implantable fluid access port via a coupling agent proximate to the top surface of the porous coupling member for mating with the base of the implantable access port. The porous coupling member may extend in a plane substantially parallel to the base of the bottom housing section and may be configured for anchoring the port to the tissue of the patient. The porous coupling member may be made from injection moldable plastic or rubber. The porous coupling member may be formed as a partial ring shape or a substantially circular shape. The porous coupling member may extend in a plane substantially parallel to the base of the port, including a first portion (proximate to the implantable access port) and a second portion. The first portion may not include a porous surface and the second portion may include a porous surface. The surface that does not include a porous surface may be configured to shield a portion of the patient from contact with a needle.
The implantable fluid access port may further include a guard plate configured to shield the bottom exit tube coupling and/or a tube from contact with a needle. The guard plate may include channels or openings configured to allow fluid to pass from the partial interior vessel to the bottom exit tube coupling. The guard plate may be internal to the partial interior vessel. The bottom housing section may include surface features for positioning a guard plate and/or channeling fluid from the partial interior vessel to the bottom exit tube coupling.
In one embodiment, the bottom exit tube coupling may further include a ball joint socket structure and/or coupling technique. In this embodiment, the bottom exit tube coupling may include a boot.
In some embodiments, the bottom exit tube coupling may be made from a silicon rubber material. The top housing section and the bottom housing section may couple together to place the septum surface under compression. The top housing section and the bottom housing section may be securably coupled together via locking tabs.
In some embodiments, the implantable fluid access port may further include a mesh material oriented between the implantable access port and a coupling member. A through hole in the mesh material may be configured to allow the coupler to pass through the through hole to mate with the base of the implantable access port. This way, the mesh may be sandwichably held in position. The mesh material may be a pre-fabricated mesh material made from injection moldable plastic or rubber. The port may be implanted subcutaneously.
In one embodiment, a method of securably coupling an implantable fluid access port of an adjustable gastric banding system configured to facilitate fluid transfer to and from the gastric banding system is disclosed. The method may include subcutaneously coupling an implantable fluid access port having a bottom exit tube coupling to the tissue of a patient, and coupling the tube of an adjustable gastric banding system to the bottom exit tube coupling.
The method may include protecting the bottom exit tube coupling via a guard plate internal to the port. In some embodiments, the bottom exit tube coupling is made from a silicon rubber material. The port may include a septum configured to receive a needle for fluid transfer. The subcutaneous coupling may be performed via a mesh material oriented between the implantable access port and a coupling member, sutures, and/or using a porous coupler.
These and other aspects and embodiments of the present invention may be more clearly understood or appreciated by referring to the accompanying drawings and the detailed description.
The present invention relates to implantable medical devices and fasteners therefore and more specifically to access ports and methods for applying the same to bodily tissue. Specifically, the present invention is directed to a subcutaneous implantable gastric banding system including a subcutaneously attached access port coupled to bodily tissue. In some embodiments, a tube and component guard plate, a flexible exit tube coupling and/or a flexibly oriented exit tube coupling, bottom exit tube orientation and/or a tissue guard may reduce pain caused by errant needle sticks/strikes or reduce the need for follow-up surgery to repair damaged components.
In various embodiments, the present invention utilizes tube guards, component guards, tissue shields, pre-fabricated mesh and porous coupling devices and/or combinations thereof to protect the patient from unnecessary pain or discomfort. In some embodiments, a mesh material and/or coupling device (described in greater detail below) may be used to anchor an access port to a patient's tissue. For example, the mesh material may encourage tissue ingrowth or tissue engagement through holes and spaces of the mesh material. This use of mesh materials to anchor the access port using the patient's own tissue engagement may obviate the need for sutures during implantation. For example, where access port implantation may occur using sutures, during recovery and beyond, movement of the patient may cause discomfort due to a pulling and slight tearing of the tissue around the implantation site. Use of a porous coupling device or prefabricated mesh material according to embodiments of the present invention may eliminate or substantially reduce this discomfort.
In accordance with various embodiments,
In various embodiments, the access port 10 comprises at least one anchoring surface 8. The anchoring surface 8 may comprise any suitable anchoring surface, such as a latch, clip, hole, ridge, recess, surface deformity, notch, flange and/or the like. The housing of the access port 10 may comprise any suitable geometry, such as conical, cylindrical, square, block, and/or the like. The side wall of the housing of the access port 10 may comprise a surface transition to assist the operation of the anchoring surface 8.
With continued reference to
In one embodiment, as illustrated in
Further, in an embodiment, a portion of the coupler 20 may be porous. For example, a plurality of through holes 22 may pass from the top surface to the bottom surface of the coupler 20. These through holes 22 may be configured to allow for tissue ingrowth or tissue engagement through the through holes 22 to serve as or assist with the anchoring of the port 10 with the patient. The through holes 22 may be formed in any configuration. For example, the spacing of the holes may be regular or irregular. The through holes 22 may be formed in substantially the entire surface of the coupler 20 or the through holes 22 may be located in a particular portion(s) of the coupler 20. For example, the through holes 22 may be located towards the outer perimeter of the coupler 20 leaving a portion of the surface without through holes 22 proximate the base of the port 10.
Further, in accordance with various embodiments,
In one embodiment, the coupler 20 may comprise one or more flanges (not depicted) configured to support the flexing of the anchoring surface of the patient, such as the patient's abdominal wall adjacent to and coupled to the bottom surface of the coupler 20. For example, the flange 26 may be formed by forming a groove in the coupler 20. The coupler 20 may be made from any suitable material. For example, the coupler 20 may be made from an injection molded plastic material, injection molded rubber material, compression molded material, transfer molded material, over-molded plastic over mesh, and/or the like. In one embodiment, the coupler 20 may be integral to a surface, such as the bottom surface of the port 10.
Turning now to
With further reference to
In this manner, the body's own tissue may grow into the coupler 20 and act as an anchoring mechanism. This anchoring mechanism may be more comfortable for the patient post surgery than previous access port anchoring methods and techniques.
In another embodiment, a mesh material may be molded onto a biocompatible material such as injection molded plastic or a rubber coupler having the coupling agents 24. In one embodiment, the pre-fabricated mesh material may be sandwichably oriented between the access port 10 and a clip or coupler. Principles of the present disclosure may suitably be combined with design and principles for implantable ports and mesh material as disclosed in a co-pending U.S. patent application Ser. No. 12/904,422, entitled “IMPLANTABLE COUPLING DEVICE” filed on Oct. 14, 2010, the contents of which is hereby incorporated by reference in its entirety.
Turning now to
The top housing section 12 comprises a substantially circular side wall and a substantially ring shaped top opening. The top opening may be sized to permit suitable access to the septum surface 15. The thickness and height of the substantially circular side wall may be any suitable thickness. The interior of the top housing section 20, as shown in
The septum 15 may be any suitable shape or dimension. In one embodiment, the thickness and diameter of the substantially circular septum 15 is sized to be secured in place by an interference fit between the top housing section 12 and the bottom housing section 14. The septum 15 may be made from any suitable material configured to be self-sealing after the puncture of a needle.
The bottom exit tube coupling 16 may be configured to be coupled to the tube 6. In this manner, the bottom exit tube coupling 16 may facilitate the transfer of fluid from the port to the tube 6. The bottom exit tube coupling 16 is oriented to couple with the tube 6 in a direction substantially normal to the bottom surface of the port 10, such as the bottom surface of the bottom housing section 14, away from the port 10. Stated another way, the connection of the port 10 to the tube 6 is downward (e.g. out the bottom of the port).
The first end of the bottom exit tube coupling 16 is shaped and sized for any suitable coupling, such as for an interference fit, with a portion of the bottom housing section 14 (as shown in
Moreover, the bottom exit tube coupling 16 may be made from a relatively flexible (non-rigid) material, such as a silicon rubber material, to provide generous strain relief to movement at the base of the port 10 and/or to aid in reducing the discomfort to the patient as compared with previous rigid tube coupling structures.
The length of the channel on the bottom exit tube coupling 16 between the bottom of the bottom housing section 14 and the connection with the tube 6 may be any suitable length. For instance, the length between the bottom of the bottom housing section 14 and the connection with the tube 6 may be about a centimeter or the length may be tens of centimeters.
As discussed above, the bottom housing section 14 is shaped to securably couple to the top housing section 12 via any suitable coupling method, such as via an interference fit or press fit, or by being clamped, adhered using adhesive, or otherwise coupled to the top housing section 12. The interior of the bottom housing section comprises a substantially ring shaped opening. The bottom surface of the septum 15 and the interior surface of the bottom housing section 14 form a partial interior vessel of the port. The bottom housing section 14 further comprises surface features for housing the guard plate 30. These surface features may include an opening for the guard plate 30 to be press fit into, where the opening is slightly smaller than the diameter of the guard plate 30 creating a tight press fit between the bottom housing section 14 and the guard plate 30. The bottom housing section 14 surface features may be raised support elements 31 to lift the guard plate 30 above a channel(s) 35 in the bottom exit tube coupling 34 and/or the bottom interior surface of the bottom housing section 14 may be fashioned into channels to allow the passage of fluid. For instance, these channels allow the passage of a fluid from the partial interior vessel of the port 10 through strategically placed openings 32 in the guard plate 30 to the bottom exit tube coupling 16 and to the tube 6.
The guard plate 30 may be secured to the bottom housing section 14 by any suitable means, such as through an interference fit. In another embodiment, the guard plate 30 may have more or fewer openings (as compared to
In one embodiment, the openings 32 in the guard plate 30 may be narrow, long openings sized smaller than the diameter of the needle point to reduce the likelihood of the needle becoming stuck in the opening 32. These openings 32 may be placed towards the edge of the guard plate 30 passing from the top surface of the guard plate 30 to the bottom surface of the guard plate 30. The guard plate 30 may be any suitable shape such as a flat disc shape. In other embodiments, the guard plate 30 may be shaped with a tapering bottom or other surface features or markings such as grooves or slots to position the guard plate 30 in a specified orientation.
Optionally, and with reference to
An implantable port device 210 according to various embodiments is depicted in
The interface between the first end of the bottom exit coupling 216 and the bottom housing section 214 is a fluid tight ball joint system. This ball joint system may include a rounded top section configured to sit in a mating rounded bottom opening of the bottom housing section 214 having a slight taper. In this manner the bottom exit coupling 216 may move and/or rotate without losing the fluid seal in the internal vessel.
In this embodiment, the orientation of the tube 6 and/or the position of the surrounding tissue can dictate the orientation of the bottom exit tube coupling 216. This may reduce discomfort by the patient and reduce stress and strain on the tube 6 as the patient moves. In this embodiment, the bottom exit coupling 216 may be made from any suitable material such as a rubber or a semi-rigid or rigid medical grade plastic or polymer.
A top plate 245 (as shown in
Optionally, a boot 246 may be coupled around a portion of the bottom exit coupling 216 and to the bottom exterior surface of the bottom housing section 214 to form a secondary fluid seal. The boot 246 may be coupled to the bottom exit coupling 216 by any suitable means such as a press fit. Also, the boot 246 may be coupled to the bottom housing section 214 by any suitable means, such as with a press fit and/or by being adhered. The boot 246 may be made from any suitable material, such as a flexible rubber material.
In one embodiment, a guard plate 230 may be coupled to the partial interior vessel of the port 210 to protect the internal port 210 elements from needle strikes. Optionally, the coupler 220 may be replaced with a suture, mesh or other coupling means.
Another configuration of an implantable port device 310, according to various embodiments, is depicted in
The septum 315 may be inserted up, into and/or partially through the top cap 352. The internal ring 354 may be placed between the guard plate 330 and the septum 315. The molded flange 358 may be inserted down into and at least partially through the bottom cap 360. The septum 315, the internal ring 354 and the guard plate 330 may be inserted into the bottom cap 360. The septum 315 and the top cap 352 may be mated with the bottom cap 360 and other elements of port 310. One or more locking tabs 356 may be inserted into apertures to securably couple the top cap 352 to the bottom cap 360. An internal fluid seal is created by assembling the implantable port device 310 as described above.
In one embodiment, the septum 315 may be made from silicon rubber. The formed rim of the septum 315 is under compression creating a fluid tight seal after assembly is complete. The internal ring 354 holds down the guard plate 330 and aids in creating the seal against the septum 315.
In one embodiment, as shown in
The clearance between the edge of the metal plate and several locations (such as indentations 332) on the molded flange 358 allow the fluid internal to the port 310 to transfer from the internal vessel of the port 310 to the molded flange 358 through the channels 335 molded into the geometry of the molded flange 358. Additionally, structural support to lift the guard plate 330 above the channels 335 is provided by molded portions 331 in the molded flange 358. In an embodiment, the coupler 318 may be replaced with a porous coupling member, mesh or other coupling means. The molded flange 358 may be made of any suitable material for flexing, such as molded silicon rubber. Additionally, strain relief on the molded flange 358 may be increased if desired by altering the geometry of the molded flange 358.
The conduit towards the bottom of and integral to the molded flange 358 may be made from any suitable material. For instance, the molded flange 358 may be made from one or more materials such as silicon rubber. A silicon rubber conduit allows for generous strain relief at the potential flex points with no metal or rigid stem connector. The rigid stem connector may increase the joint stress at the tube 6 coupling point.
Previous ports have utilized side exiting and/or rigid tube coupling structures (as depicted in
The bottom exit tube coupling 358 orientation in the downward direction (relative to the base of the port 310) reduces the stress and strain placed on the tube 6 by reducing the need to bend the tube 6 from the relatively horizontal direction to the relatively horizontal direction as compared with a side exiting tube coupling. Also, the orientation of the bottom exit tube coupling 358 naturally protects the tube 6 from needle puncture. In this manner, the body of the implantable port 310 and the direction of needle insertion substantially in line with the bottom exit tube coupling 358 may protect the needle from puncture. Additionally, the physical structure of the bottom exit tube coupling 358, which exits via the base of the port 310 substantially inline with the needle insertion direction, stabilizes the position of the port 310. This physical structure (i.e., a bottom exit port coupling 358 as shown in
In one embodiment, the elements of the implantable port and/or coupler may be coated with a bioresorbable material, for example, to encourage biological compatibility between the device elements and the body tissue. The coating may cover the entirety of the device elements or only a portion of the device elements. A thickness of the coating may be even, or may vary along the surface of the device elements. The coating may be deposited through a process including a spraying process, dipping process, molding process, wiping process, or other equivalent means of attaching the bioresorbable material to the device elements. The coating thickness may vary between approximately 0.001 inches and 0.25 inches. The bioresorbable material serves to form a biological seal between the access port 10 and the body tissue, and to encourage compatibility between the access port 10 and the body tissue.
The implantable ports described herein may comprise any suitable shape. For instance, the ports may be generally conical, cylindrical, cubical, rectangular prism, or irregularly shaped. In this manner, the ports may comprise substantially circular side walls or non-circular side walls. Also, the ports may comprise top and bottom surfaces with any suitable geometric or non-geometric shape.
The terms “a,” “an,” “the” and similar referents used in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. Recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member may be referred to and claimed individually or in any combination with other members of the group or other elements found herein. It is anticipated that one or more members of a group may be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.
Certain embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventor expects skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.
Specific embodiments disclosed herein may be further limited in the claims using “consisting of” or “consisting essentially of” language. When used in the claims, whether as filed or added per amendment, the transition term “consisting of” excludes any element, step, or ingredient not specified in the claims. The transition term “consisting essentially of” limits the scope of a claim to the specified materials or steps and those that do not materially affect the basic and novel characteristic(s). Embodiments of the invention so claimed are inherently or expressly described and enabled herein.
In closing, it is to be understood that the embodiments of the invention disclosed herein are illustrative of the principles of the present invention. Other modifications that may be employed are within the scope of the invention. Thus, by way of example, but not of limitation, alternative configurations of the present invention may be utilized in accordance with the teachings herein. Accordingly, the present invention is not limited to that precisely as shown and described.
This application is a continuation-in-part of, and claims priority to and the benefit of U.S. patent application Ser. No. 12/904,422, entitled “IMPLANTABLE COUPLING DEVICE” filed on Oct. 14, 2010, which is a continuation-in-part of U.S. patent application Ser. No. 12/772,039, entitled “SYSTEM INCLUDING ACCESS PORT AND APPLICATOR TOOL” filed on Apr. 30, 2010, which claims priority to and the benefit of U.S. Provisional patent application No. 61/237,641, filed on Aug. 27, 2009, and U.S. Provisional patent application No. 61/236,869, filed on Aug. 26, 2009, all of these applications are hereby expressly incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
586113 | Bott | Jul 1897 | A |
2163048 | McKee | Jun 1939 | A |
2737954 | Knapp | Mar 1956 | A |
3371352 | Siposs et al. | Mar 1968 | A |
3569660 | Houldcroft | Mar 1971 | A |
3587115 | Shiley | Jun 1971 | A |
3596660 | Melone | Aug 1971 | A |
3667081 | Burger | Jun 1972 | A |
3688764 | Reed | Sep 1972 | A |
3840018 | Heifetz | Oct 1974 | A |
3958562 | Hakim et al. | May 1976 | A |
3971376 | Wichterle | Jul 1976 | A |
4019499 | Fitzgerald | Apr 1977 | A |
4118805 | Reimels | Oct 1978 | A |
4151835 | Showell et al. | May 1979 | A |
4161943 | Nogier | Jul 1979 | A |
4164943 | Hill et al. | Aug 1979 | A |
4190040 | Schulte | Feb 1980 | A |
4233992 | Bisping | Nov 1980 | A |
4265252 | Chubbuck et al. | May 1981 | A |
4280722 | Guptil et al. | Jul 1981 | A |
4413985 | Wellner | Nov 1983 | A |
4474572 | McNaughton et al. | Oct 1984 | A |
4502335 | Wamstad et al. | Mar 1985 | A |
4543088 | Bootman et al. | Sep 1985 | A |
4557722 | Harris | Dec 1985 | A |
4569675 | Prosl et al. | Feb 1986 | A |
4588394 | Schulte et al. | May 1986 | A |
4592339 | Kuzmak et al. | Jun 1986 | A |
4592355 | Antebi | Jun 1986 | A |
4634427 | Hannula et al. | Jan 1987 | A |
4655765 | Swift | Apr 1987 | A |
4673394 | Fenton, Jr. et al. | Jun 1987 | A |
4692146 | Hilger | Sep 1987 | A |
4696288 | Kuzmak et al. | Sep 1987 | A |
4704103 | Stober et al. | Nov 1987 | A |
4710174 | Moden et al. | Dec 1987 | A |
4738657 | Hancock et al. | Apr 1988 | A |
4767410 | Moden et al. | Aug 1988 | A |
4772270 | Wiita et al. | Sep 1988 | A |
4778452 | Moden et al. | Oct 1988 | A |
4781680 | Redmond et al. | Nov 1988 | A |
4796641 | Mills et al. | Jan 1989 | A |
4802885 | Weeks et al. | Feb 1989 | A |
4832054 | Bark | May 1989 | A |
4840615 | Hancock et al. | Jun 1989 | A |
4850227 | Luettgen et al. | Jul 1989 | A |
4858623 | Bradshaw et al. | Aug 1989 | A |
4861341 | Woodburn | Aug 1989 | A |
4881939 | Newman | Nov 1989 | A |
4886501 | Johnston et al. | Dec 1989 | A |
4902278 | Maget et al. | Feb 1990 | A |
4904241 | Bark | Feb 1990 | A |
4913702 | Yum et al. | Apr 1990 | A |
4915690 | Cone et al. | Apr 1990 | A |
4929230 | Pfleger | May 1990 | A |
4929236 | Sampson | May 1990 | A |
4966588 | Rayman et al. | Oct 1990 | A |
4967755 | Pohndorf | Nov 1990 | A |
4978338 | Melsky et al. | Dec 1990 | A |
5006115 | McDonald | Apr 1991 | A |
5013298 | Moden et al. | May 1991 | A |
5026344 | Dijkstra et al. | Jun 1991 | A |
5041098 | Loiterman et al. | Aug 1991 | A |
5045060 | Melsky et al. | Sep 1991 | A |
5074868 | Kuzmak | Dec 1991 | A |
5090954 | Geary | Feb 1992 | A |
5092897 | Forte | Mar 1992 | A |
5094244 | Callahan et al. | Mar 1992 | A |
5098397 | Svensson | Mar 1992 | A |
5108377 | Cone et al. | Apr 1992 | A |
5125408 | Basser | Jun 1992 | A |
5133753 | Bark et al. | Jul 1992 | A |
5137529 | Watson et al. | Aug 1992 | A |
5147483 | Melsky et al. | Sep 1992 | A |
5152747 | Olivier | Oct 1992 | A |
5167638 | Felix et al. | Dec 1992 | A |
5185003 | Brethauer | Feb 1993 | A |
5207644 | Strecker | May 1993 | A |
5213574 | Tucker | May 1993 | A |
5226429 | Kuzmak | Jul 1993 | A |
5226894 | Haber et al. | Jul 1993 | A |
5250026 | Ehrlich et al. | Oct 1993 | A |
5273537 | Haskvitz et al. | Dec 1993 | A |
5281205 | McPherson | Jan 1994 | A |
5284479 | de Jong | Feb 1994 | A |
5318545 | Tucker | Jun 1994 | A |
5336194 | Polaschegg et al. | Aug 1994 | A |
5337747 | Neftel | Aug 1994 | A |
5360407 | Leonard et al. | Nov 1994 | A |
5368040 | Carney | Nov 1994 | A |
5387192 | Glantz et al. | Feb 1995 | A |
5391164 | Giampapa | Feb 1995 | A |
5449368 | Kuzmak | Sep 1995 | A |
5476460 | Montalvo | Dec 1995 | A |
5514174 | Heil, Jr. et al. | May 1996 | A |
5540648 | Yoon | Jul 1996 | A |
5556388 | Johlin, Jr. | Sep 1996 | A |
5558641 | Glantz et al. | Sep 1996 | A |
5562617 | Finch, Jr. et al. | Oct 1996 | A |
5571104 | Li | Nov 1996 | A |
5575777 | Cover et al. | Nov 1996 | A |
5601604 | Vincent | Feb 1997 | A |
5637102 | Tolkoff et al. | Jun 1997 | A |
5653755 | Ledergerber | Aug 1997 | A |
5658298 | Vincent et al. | Aug 1997 | A |
5674397 | Pawlak et al. | Oct 1997 | A |
5683447 | Bush et al. | Nov 1997 | A |
5688237 | Rozga et al. | Nov 1997 | A |
5695490 | Flaherty et al. | Dec 1997 | A |
5716342 | Dumbraveanu et al. | Feb 1998 | A |
5718682 | Tucker | Feb 1998 | A |
5722957 | Steinbach | Mar 1998 | A |
5748200 | Funahashi | May 1998 | A |
5810735 | Halperin et al. | Sep 1998 | A |
5814019 | Steinbach et al. | Sep 1998 | A |
5833654 | Powers et al. | Nov 1998 | A |
5843033 | Ropiak | Dec 1998 | A |
RE36176 | Kuzmak | Mar 1999 | E |
5883654 | Katsuyama | Mar 1999 | A |
5902598 | Chen et al. | May 1999 | A |
5906596 | Tallarida | May 1999 | A |
5910149 | Kuzmak | Jun 1999 | A |
5911704 | Humes | Jun 1999 | A |
5931829 | Burbank et al. | Aug 1999 | A |
5932460 | Mills et al. | Aug 1999 | A |
5935083 | Williams | Aug 1999 | A |
5938669 | Klaiber et al. | Aug 1999 | A |
5951512 | Dalton | Sep 1999 | A |
6024704 | Meador et al. | Feb 2000 | A |
6030369 | Engelson et al. | Feb 2000 | A |
6039712 | Fogarty et al. | Mar 2000 | A |
6074341 | Anderson et al. | Jun 2000 | A |
6090066 | Schnell | Jul 2000 | A |
6098405 | Miyata et al. | Aug 2000 | A |
6102678 | Peclat | Aug 2000 | A |
6102922 | Jakobsson et al. | Aug 2000 | A |
6123700 | Mills et al. | Sep 2000 | A |
6152885 | Taepke | Nov 2000 | A |
6171252 | Roberts | Jan 2001 | B1 |
6183449 | Sibbitt | Feb 2001 | B1 |
6213973 | Eliasen et al. | Apr 2001 | B1 |
6221024 | Miesel | Apr 2001 | B1 |
6234973 | Meador et al. | May 2001 | B1 |
6258079 | Burbank et al. | Jul 2001 | B1 |
6264676 | Gellman et al. | Jul 2001 | B1 |
6270475 | Bestetti | Aug 2001 | B1 |
6283949 | Roorda | Sep 2001 | B1 |
6321124 | Cigaina | Nov 2001 | B1 |
6349740 | Cho et al. | Feb 2002 | B1 |
6432040 | Meah | Aug 2002 | B1 |
6450946 | Forsell | Sep 2002 | B1 |
6453907 | Forsell | Sep 2002 | B1 |
6454699 | Forsell | Sep 2002 | B1 |
6459917 | Gowda et al. | Oct 2002 | B1 |
6461293 | Forsell | Oct 2002 | B1 |
6464628 | Forsell | Oct 2002 | B1 |
6470213 | Alley | Oct 2002 | B1 |
6470892 | Forsell | Oct 2002 | B1 |
6478783 | Moorehead | Nov 2002 | B1 |
6511490 | Robert | Jan 2003 | B2 |
6547801 | Dargent et al. | Apr 2003 | B1 |
6572587 | Lerman et al. | Jun 2003 | B2 |
6589184 | Noren et al. | Jul 2003 | B2 |
6648849 | Tenhuisen et al. | Nov 2003 | B2 |
6666845 | Hooper et al. | Dec 2003 | B2 |
6689100 | Connelly et al. | Feb 2004 | B2 |
6723053 | Ackerman et al. | Apr 2004 | B2 |
6733519 | Lashinski et al. | May 2004 | B2 |
6792309 | Noren | Sep 2004 | B1 |
6810880 | Jennings, Jr. et al. | Nov 2004 | B1 |
6813964 | Clark et al. | Nov 2004 | B1 |
6860857 | Noren et al. | Mar 2005 | B2 |
6915162 | Noren et al. | Jul 2005 | B2 |
6921267 | van Oostrom et al. | Jul 2005 | B2 |
6929631 | Brugger et al. | Aug 2005 | B1 |
6939299 | Petersen et al. | Sep 2005 | B1 |
6953444 | Rosenberg | Oct 2005 | B2 |
6964204 | Clark et al. | Nov 2005 | B2 |
6966875 | Longobardi | Nov 2005 | B1 |
6997914 | Smith et al. | Feb 2006 | B2 |
7017583 | Forsell | Mar 2006 | B2 |
7020531 | Colliou et al. | Mar 2006 | B1 |
7056286 | Ravenscroft et al. | Jun 2006 | B2 |
7063669 | Brawner et al. | Jun 2006 | B2 |
7073387 | Zdeblick et al. | Jul 2006 | B2 |
7082843 | Clark et al. | Aug 2006 | B2 |
7131945 | Fink et al. | Nov 2006 | B2 |
7144400 | Byrum et al. | Dec 2006 | B2 |
7149587 | Wardle et al. | Dec 2006 | B2 |
7191007 | Desai et al. | Mar 2007 | B2 |
7195774 | Carvalho et al. | Mar 2007 | B2 |
7223239 | Schulze | May 2007 | B2 |
7226419 | Lane et al. | Jun 2007 | B2 |
7261003 | McDonald et al. | Aug 2007 | B2 |
7267645 | Anderson et al. | Sep 2007 | B2 |
7282023 | Frering | Oct 2007 | B2 |
7311716 | Byrum | Dec 2007 | B2 |
7311717 | Egle | Dec 2007 | B2 |
7351198 | Byrum et al. | Apr 2008 | B2 |
7351226 | Herskowitz | Apr 2008 | B1 |
7351240 | Hassler, Jr. et al. | Apr 2008 | B2 |
7353747 | Swayze et al. | Apr 2008 | B2 |
7364542 | Jambor et al. | Apr 2008 | B2 |
7367937 | Jambor et al. | May 2008 | B2 |
7374557 | Conlon | May 2008 | B2 |
7374565 | Hassler, Jr. et al. | May 2008 | B2 |
7390294 | Hassler, Jr. | Jun 2008 | B2 |
7413547 | Lichtscheidl et al. | Aug 2008 | B1 |
7416528 | Crawford et al. | Aug 2008 | B2 |
7437951 | McDonald et al. | Oct 2008 | B2 |
7438718 | Milliman et al. | Oct 2008 | B2 |
7445614 | Bunodiere et al. | Nov 2008 | B2 |
7468038 | Ye et al. | Dec 2008 | B2 |
7500944 | Byrum et al. | Mar 2009 | B2 |
7510530 | Hashimoto et al. | Mar 2009 | B2 |
7530943 | Lechner | May 2009 | B2 |
7553298 | Hunt | Jun 2009 | B2 |
7561916 | Hunt | Jul 2009 | B2 |
7580746 | Gilkerson et al. | Aug 2009 | B2 |
7591185 | Mothilal et al. | Sep 2009 | B1 |
7593777 | Gerber | Sep 2009 | B2 |
7634319 | Schneider et al. | Dec 2009 | B2 |
7651483 | Byrum | Jan 2010 | B2 |
7658196 | Ferreri et al. | Feb 2010 | B2 |
7699770 | Hassler, Jr. et al. | Apr 2010 | B2 |
7708722 | Glenn | May 2010 | B2 |
7762998 | Birk et al. | Jul 2010 | B2 |
7762999 | Byrum | Jul 2010 | B2 |
7775215 | Hassler, Jr. et al. | Aug 2010 | B2 |
7775966 | Dlugos et al. | Aug 2010 | B2 |
7811275 | Birk et al. | Oct 2010 | B2 |
7850660 | Uth et al. | Dec 2010 | B2 |
7862546 | Conlon et al. | Jan 2011 | B2 |
7909754 | Hassler, Jr. et al. | Mar 2011 | B2 |
7909804 | Stats | Mar 2011 | B2 |
8007474 | Uth et al. | Aug 2011 | B2 |
20010052141 | Andersen | Dec 2001 | A1 |
20020013545 | Soltanpour et al. | Jan 2002 | A1 |
20020058969 | Noren et al. | May 2002 | A1 |
20020087147 | Hooper et al. | Jul 2002 | A1 |
20020095181 | Beyer | Jul 2002 | A1 |
20020139208 | Yatskov | Oct 2002 | A1 |
20020198548 | Robert | Dec 2002 | A1 |
20030045800 | Noren et al. | Mar 2003 | A1 |
20030045910 | Sorensen et al. | Mar 2003 | A1 |
20030073880 | Polsky et al. | Apr 2003 | A1 |
20030078506 | Noren et al. | Apr 2003 | A1 |
20030139690 | Aebli et al. | Jul 2003 | A1 |
20040064110 | Forsell | Apr 2004 | A1 |
20040065615 | Hooper et al. | Apr 2004 | A1 |
20040068233 | DiMatteo | Apr 2004 | A1 |
20040082908 | Whitehurst et al. | Apr 2004 | A1 |
20040111050 | Smedley et al. | Jun 2004 | A1 |
20040204692 | Eliasen | Oct 2004 | A1 |
20040254536 | Conlon et al. | Dec 2004 | A1 |
20040254537 | Conlon | Dec 2004 | A1 |
20040260229 | Meir | Dec 2004 | A1 |
20040260319 | Egle | Dec 2004 | A1 |
20040267288 | Byrum et al. | Dec 2004 | A1 |
20040267291 | Byrum et al. | Dec 2004 | A1 |
20040267292 | Byrum et al. | Dec 2004 | A1 |
20040267293 | Byrum et al. | Dec 2004 | A1 |
20040267377 | Egle | Dec 2004 | A1 |
20050010177 | Tsai | Jan 2005 | A1 |
20050049578 | Tu et al. | Mar 2005 | A1 |
20050070875 | Kulessa | Mar 2005 | A1 |
20050070937 | Jambor et al. | Mar 2005 | A1 |
20050085778 | Parks | Apr 2005 | A1 |
20050092093 | Kang et al. | May 2005 | A1 |
20050131325 | Chen et al. | Jun 2005 | A1 |
20050131352 | Conlon | Jun 2005 | A1 |
20050131383 | Chen et al. | Jun 2005 | A1 |
20050148956 | Conlon | Jul 2005 | A1 |
20050149143 | Libbus et al. | Jul 2005 | A1 |
20050209573 | Brugger et al. | Sep 2005 | A1 |
20050240155 | Conlon | Oct 2005 | A1 |
20050240156 | Conlon | Oct 2005 | A1 |
20050267500 | Hassler, Jr. et al. | Dec 2005 | A1 |
20050277899 | Conlon | Dec 2005 | A1 |
20050283041 | Egle | Dec 2005 | A1 |
20050283118 | Uth et al. | Dec 2005 | A1 |
20050283119 | Uth | Dec 2005 | A1 |
20060074439 | Garner et al. | Apr 2006 | A1 |
20060122578 | Lord et al. | Jun 2006 | A1 |
20060161186 | Hassler, Jr. et al. | Jul 2006 | A1 |
20060173423 | Conlon | Aug 2006 | A1 |
20060173424 | Conlon | Aug 2006 | A1 |
20060178647 | Stats | Aug 2006 | A1 |
20060178648 | Barron et al. | Aug 2006 | A1 |
20060184141 | Smith et al. | Aug 2006 | A1 |
20060189887 | Hassler, Jr. et al. | Aug 2006 | A1 |
20060189888 | Hassler, Jr. et al. | Aug 2006 | A1 |
20060190039 | Birk | Aug 2006 | A1 |
20060199997 | Hassler, Jr. et al. | Sep 2006 | A1 |
20060211912 | Dlugos et al. | Sep 2006 | A1 |
20060211913 | Dlugos et al. | Sep 2006 | A1 |
20060211914 | Hassler, Jr. et al. | Sep 2006 | A1 |
20060217668 | Schulze et al. | Sep 2006 | A1 |
20060217673 | Schulze et al. | Sep 2006 | A1 |
20060235445 | Birk | Oct 2006 | A1 |
20060235448 | Roslin et al. | Oct 2006 | A1 |
20060247539 | Schugt et al. | Nov 2006 | A1 |
20060266128 | Clark et al. | Nov 2006 | A1 |
20060293625 | Hunt et al. | Dec 2006 | A1 |
20060293626 | Byrum et al. | Dec 2006 | A1 |
20060293627 | Byrum | Dec 2006 | A1 |
20060293628 | Hunt et al. | Dec 2006 | A1 |
20070010790 | Byrum et al. | Jan 2007 | A1 |
20070015954 | Dlugos | Jan 2007 | A1 |
20070015955 | Tsonton | Jan 2007 | A1 |
20070016231 | Jambor et al. | Jan 2007 | A1 |
20070027356 | Ortiz | Feb 2007 | A1 |
20070038255 | Kieval et al. | Feb 2007 | A1 |
20070060959 | Salo et al. | Mar 2007 | A1 |
20070073250 | Schneiter | Mar 2007 | A1 |
20070078391 | Wortley | Apr 2007 | A1 |
20070088336 | Dalton | Apr 2007 | A1 |
20070088391 | McAlexander | Apr 2007 | A1 |
20070129765 | Gilkerson et al. | Jun 2007 | A1 |
20070135758 | Childers et al. | Jun 2007 | A1 |
20070149947 | Byrum | Jun 2007 | A1 |
20070156013 | Birk | Jul 2007 | A1 |
20070158769 | You | Jul 2007 | A1 |
20070161958 | Glenn | Jul 2007 | A1 |
20070167672 | Dlugos et al. | Jul 2007 | A1 |
20070173685 | Jambor et al. | Jul 2007 | A1 |
20070185462 | Byrum | Aug 2007 | A1 |
20070191717 | Rosen et al. | Aug 2007 | A1 |
20070205384 | Kurosawa | Sep 2007 | A1 |
20070208313 | Conlon | Sep 2007 | A1 |
20070213837 | Ferreri et al. | Sep 2007 | A1 |
20070219510 | Zinn et al. | Sep 2007 | A1 |
20070235083 | Dlugos | Oct 2007 | A1 |
20070250086 | Wiley et al. | Oct 2007 | A1 |
20070255165 | Uesugi et al. | Nov 2007 | A1 |
20070255234 | Haase et al. | Nov 2007 | A1 |
20070265666 | Roberts et al. | Nov 2007 | A1 |
20070282196 | Birk et al. | Dec 2007 | A1 |
20070293829 | Conlon et al. | Dec 2007 | A1 |
20080009680 | Hassler, Jr. | Jan 2008 | A1 |
20080015406 | Dlugos et al. | Jan 2008 | A1 |
20080039772 | Chantriaux et al. | Feb 2008 | A1 |
20080058632 | Tai et al. | Mar 2008 | A1 |
20080097496 | Chang et al. | Apr 2008 | A1 |
20080114308 | di Palma et al. | May 2008 | A1 |
20080119798 | Chantriaux et al. | May 2008 | A1 |
20080243093 | Kalpin et al. | Oct 2008 | A1 |
20080249806 | Dlugos et al. | Oct 2008 | A1 |
20080250340 | Dlugos et al. | Oct 2008 | A1 |
20080250341 | Dlugos et al. | Oct 2008 | A1 |
20080255403 | Voegele et al. | Oct 2008 | A1 |
20080255414 | Voegele et al. | Oct 2008 | A1 |
20080255425 | Voegele et al. | Oct 2008 | A1 |
20080255459 | Voegele et al. | Oct 2008 | A1 |
20080255537 | Voegele et al. | Oct 2008 | A1 |
20080281412 | Smith et al. | Nov 2008 | A1 |
20080287969 | Tsonton et al. | Nov 2008 | A1 |
20080287974 | Widenhouse et al. | Nov 2008 | A1 |
20080312553 | Timmons | Dec 2008 | A1 |
20080319435 | Rioux et al. | Dec 2008 | A1 |
20090018608 | Schwartz et al. | Jan 2009 | A1 |
20090048524 | Wildau et al. | Feb 2009 | A1 |
20090054914 | Lechner | Feb 2009 | A1 |
20090062825 | Pool et al. | Mar 2009 | A1 |
20090071258 | Kouda et al. | Mar 2009 | A1 |
20090076466 | Quebbemann et al. | Mar 2009 | A1 |
20090082757 | Rogers et al. | Mar 2009 | A1 |
20090082793 | Birk | Mar 2009 | A1 |
20090093768 | Conlon et al. | Apr 2009 | A1 |
20090099538 | Paganon | Apr 2009 | A1 |
20090105735 | Stam et al. | Apr 2009 | A1 |
20090112308 | Kassem | Apr 2009 | A1 |
20090118572 | Lechner | May 2009 | A1 |
20090149874 | Ortiz et al. | Jun 2009 | A1 |
20090157106 | Marcotte | Jun 2009 | A1 |
20090157107 | Kierath et al. | Jun 2009 | A1 |
20090157113 | Marcotte et al. | Jun 2009 | A1 |
20090171375 | Coe et al. | Jul 2009 | A1 |
20090171378 | Coe et al. | Jul 2009 | A1 |
20090171379 | Coe et al. | Jul 2009 | A1 |
20090192404 | Ortiz et al. | Jul 2009 | A1 |
20090192415 | Ortiz et al. | Jul 2009 | A1 |
20090192533 | Dlugos, Jr. et al. | Jul 2009 | A1 |
20090192534 | Ortiz et al. | Jul 2009 | A1 |
20090192541 | Ortiz et al. | Jul 2009 | A1 |
20090198261 | Schweikert | Aug 2009 | A1 |
20090202387 | Dlugos, Jr. et al. | Aug 2009 | A1 |
20090204131 | Ortiz et al. | Aug 2009 | A1 |
20090204132 | Ortiz et al. | Aug 2009 | A1 |
20090209995 | Byrum et al. | Aug 2009 | A1 |
20090216255 | Coe et al. | Aug 2009 | A1 |
20090221974 | Paganon | Sep 2009 | A1 |
20090222031 | Axelsson | Sep 2009 | A1 |
20090222065 | Dlugos, Jr. et al. | Sep 2009 | A1 |
20090227862 | Smith et al. | Sep 2009 | A1 |
20090228028 | Coe | Sep 2009 | A1 |
20090228072 | Coe et al. | Sep 2009 | A1 |
20090248125 | Brostrom | Oct 2009 | A1 |
20090248126 | Nippoldt et al. | Oct 2009 | A1 |
20090254052 | Birk et al. | Oct 2009 | A1 |
20090259190 | Birk et al. | Oct 2009 | A1 |
20090259191 | Birk et al. | Oct 2009 | A1 |
20090259231 | Birk et al. | Oct 2009 | A1 |
20090264901 | Franklin | Oct 2009 | A1 |
20090270904 | Birk et al. | Oct 2009 | A1 |
20090299216 | Chen et al. | Dec 2009 | A1 |
20090299672 | Zhang et al. | Dec 2009 | A1 |
20090306462 | Lechner | Dec 2009 | A1 |
20090308169 | Mothilal et al. | Dec 2009 | A1 |
20100087843 | Bertolote et al. | Apr 2010 | A1 |
20100100079 | Berkcan et al. | Apr 2010 | A1 |
20100114149 | Albrecht et al. | May 2010 | A1 |
20100130941 | Conlon et al. | May 2010 | A1 |
20100152532 | Marcotte | Jun 2010 | A1 |
20100191271 | Lau et al. | Jul 2010 | A1 |
20100211085 | Uth et al. | Aug 2010 | A1 |
20100217198 | Franklin et al. | Aug 2010 | A1 |
20100217199 | Uth et al. | Aug 2010 | A1 |
20100217200 | Uth et al. | Aug 2010 | A1 |
20100228080 | Tavori et al. | Sep 2010 | A1 |
20100234808 | Uth et al. | Sep 2010 | A1 |
20110054407 | Olroyd et al. | Mar 2011 | A1 |
20110082426 | Conlon et al. | Apr 2011 | A1 |
Number | Date | Country |
---|---|---|
1250382 | Apr 2000 | CN |
1367670 | Sep 2002 | CN |
3927001 | Feb 1991 | DE |
4211045 | Oct 1993 | DE |
19751791 | May 1997 | DE |
19745654 | Apr 1999 | DE |
0343910 | Nov 1989 | EP |
0611561 | Sep 1993 | EP |
0858814 | Aug 1998 | EP |
0867197 | Sep 1998 | EP |
1057457 | Dec 2000 | EP |
1346753 | Sep 2003 | EP |
1396242 | Mar 2004 | EP |
1396243 | Mar 2004 | EP |
1488824 | Dec 2004 | EP |
1543861 | Jun 2005 | EP |
1547643 | Jun 2005 | EP |
1591140 | Nov 2005 | EP |
1736194 | Dec 2006 | EP |
1736195 | Dec 2006 | EP |
1736196 | Dec 2006 | EP |
1736197 | Dec 2006 | EP |
1736198 | Dec 2006 | EP |
1736199 | Dec 2006 | EP |
1870126 | Dec 2007 | EP |
1985263 | Oct 2008 | EP |
2070494 | Jun 2009 | EP |
2095798 | Sep 2009 | EP |
2740977 | May 1997 | FR |
2797181 | Feb 2001 | FR |
2823663 | Oct 2002 | FR |
2851168 | Aug 2004 | FR |
2855744 | Dec 2004 | FR |
2916980 | Dec 2008 | FR |
2119877 | May 1990 | JP |
8107934 | Apr 1996 | JP |
1823791 | Jun 1991 | SU |
WO 9220519 | Nov 1992 | WO |
WO 9422520 | Oct 1994 | WO |
WO 9640357 | Dec 1996 | WO |
WO 9701370 | Jan 1997 | WO |
WO 9920338 | Apr 1999 | WO |
WO 9926543 | Jun 1999 | WO |
WO 9934859 | Jul 1999 | WO |
WO 0015158 | Mar 2000 | WO |
WO 0033901 | Jun 2000 | WO |
WO 0110359 | Feb 2001 | WO |
WO 0149245 | Jul 2001 | WO |
WO 0180926 | Nov 2001 | WO |
WO 0195813 | Dec 2001 | WO |
WO 0210667 | Feb 2002 | WO |
WO 02074381 | Sep 2002 | WO |
WO 03105732 | Dec 2003 | WO |
WO 2004016971 | Mar 2004 | WO |
WO 2005037055 | Apr 2005 | WO |
WO 2005072627 | Aug 2005 | WO |
WO 2006021695 | Mar 2006 | WO |
WO 2009007526 | Jan 2009 | WO |
WO 2009129474 | Oct 2009 | WO |
Entry |
---|
Helioscopie Product Insert for Heliogast, pp. 1-11 (undated). |
Autumn K. et al.; “Evidence of Van Der Waals Adhesion in Gecko Setae”; PNAS; vol. 99; No. 19; pp. 12252-12256; Sep. 17, 2012. |
Geim AK. et al.; “Microfabricated Adhesive Mimicking Gecko Foot-Hair”; Nature Materials Abstract only; vol. 2; No. 7; 2003. |
Yamagami, Takuji; “Technical Developments: Use of Targeting Guide Wire in Left Subclavian Puncture During Percutaneous Implantation of Port-Catheter Systems Using the Catheter Tip Fixation Method” European Radiology; vol. 13; pp. 863-866; 2003. |
Yurdumakan B., et al.; “Synthetic Gecko Foot-Hairs from Multiwalled Carbon Nanotubes”; The Royal Society of Chemistry; p. 3799-3801; 2005. |
http://en/wikipedia.org/Injection—Molding, Accessed Sep. 6, 2012. |
Number | Date | Country | |
---|---|---|---|
20110218392 A1 | Sep 2011 | US |
Number | Date | Country | |
---|---|---|---|
61237641 | Aug 2009 | US | |
61236869 | Aug 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12904422 | Oct 2010 | US |
Child | 13021099 | US | |
Parent | 12772039 | Apr 2010 | US |
Child | 12904422 | US |